Synthetic cannabinoid-induced delirium

Description

Synthetic cannabinoid-induced delirium is characterised by an acute state of disturbed attention and awareness with specific features of delirium that develops during or soon after substance intoxication or withdrawal or during the use of synthetic cannabinoids. The amount and duration of synthetic cannabinoid use must be capable of producing delirium. The symptoms are not better explained by a primary mental disorder, by use of or withdrawal from a different substance, or by another health condition that is not classified under Mental, behavioural and neurodevelopmental disorders.

Index terms

Synthetic cannabinoid-induced delirium

Exclusions from above levels

6C41 – Disorders due to use of cannabis
QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Sibling codes

6C42.0 – Episode of harmful use of synthetic cannabinoids
6C42.1 – Harmful pattern of use of synthetic cannabinoids
6C42.2 – Synthetic cannabinoid dependence
6C42.3 – Synthetic cannabinoid intoxication
6C42.4 – Synthetic cannabinoid withdrawal
6C42.6 – Synthetic cannabinoid-induced psychotic disorder
6C42.7 – Certain specified synthetic cannabinoids-induced mental or behavioural disorders
6C42.Y – Other specified disorders due to use of synthetic cannabinoids
6C42.Z – Disorders due to use of synthetic cannabinoids, unspecified

Foundation entity

Synthetic cannabinoid-induced delirium – http://id.who.int/icd/entity/138091123

Allowed postcoordination axes

Part of: 6C42: Disorders due to use of synthetic cannabinoids › 06: Mental, behavioural or neurodevelopmental disorders